HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Retreatment with Hyaluronic Acid Viscosupplementation in Knee Osteoarthritis: Agreement between EUROVISCO Guidelines and Current Medical Practice.

AbstractOBJECTIVES:
This work studied if and how current clinical practice agrees with European Viscosupplementation Consensus Group (EUROVISCO) recommendations and how this agreement might be different according to physician's specialization. In addition, this work aimed to identify key decision factors that practitioners consider in their decision to retreat or not a patient with hyaluronic acid viscosupplementation.
METHODS:
Practitioners have been invited by e-mail to participate in an online exercise on viscosupplementation retreatment. They received a fictional patient case at random among a set of predefined fictional cases. The platform asked the practitioner if he/she would retreat the patient with viscosupplementation or not. To take a decision, the practitioner could select questions among a list of predefined questions. Among them, some were related to criteria used in the EUROVISCO decision tree and others served as confounding factors.
RESULTS:
A total of 506 practitioners participated to the exercise, of which 399 gave their decision about the case assigned to them by the platform. The observed agreement between practitioner decisions and EUROVISCO recommendations was 58.89 ± 4.95% (95% confidence interval [CI]). Overall, the decision to retreat was taken in 47.87% of the cases, while the EUROVISCO guidelines follow-up would have led to 55.89% retreatment for the same cases (P = 0.03).
CONCLUSIONS:
In current practice, physicians tended to reinject their patients less than recommended, although EUROVISCO guidelines for viscosupplementation retreatment consider decision criteria that clearly correspond to those of practitioners in real life. These include the patients' willingness to be treated or the patients' perception of the effectiveness of the treatment.
AuthorsYves Henrotin, Cedric Tits, Jérôme Paul, Pierre Gramme, Thibault Helleputte, Alberto Migliore, Pascal Richette, Xavier Chevalier, Jordi Monfort, Demirhan Diracoglu, Hervé Bard, Jörg Jerosch, Dominique Baron, Raman Raghu, Thierry Conrozier
JournalCartilage (Cartilage) Vol. 13 Issue 1_suppl Pg. 1696S-1701S (12 2021) ISSN: 1947-6043 [Electronic] United States
PMID34696623 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Viscosupplements
  • Hyaluronic Acid
Topics
  • Consensus
  • Female
  • Humans
  • Hyaluronic Acid (therapeutic use)
  • Osteoarthritis, Knee (drug therapy)
  • Retreatment
  • Viscosupplementation
  • Viscosupplements (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: